Amgen KRAS Inhibitor Less Effective In Colorectal Cancer Than Lung

Colon cancer. Cancer attacking cells. Colon disease concept. 3d illustration - Illustration
One of 12 colorectal cancer patients had a partial response to AMG 510. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D